Molecular Partners
MOLN
5 hedge funds and large institutions have $13.8M invested in Molecular Partners in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
0% more ownership
Funds ownership: 8.9% → 8.9% (+0%)
3% less capital invested
Capital invested by funds: $14.2M → $13.8M (-$432K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$69.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SP
SmartHarvest Portfolios
Poulsbo,
Washington
|
-$61.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCM
1
Suvretta Capital Management
New York
| $8.6M | – | – | – |
|
|
BI
2
BVF Inc
San Francisco,
California
| $5.15M | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $65.3K | +$69.7K | +17,179 | New |
|
4
Morgan Stanley
New York
| $1.42K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $1.08K | +$1.13K | +279 | New |
|
|
SP
6
SmartHarvest Portfolios
Poulsbo,
Washington
| – | -$61.7K | -15,543 | Closed |
|
MOLN Hedge Fund Activity: Q2 2026 in Review
5 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Molecular Partners (MOLN) for Q2 2026, worth a combined $13.8M — down 3% from $14.2M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MOLN positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $69.7K. The largest seller was SmartHarvest Portfolios, exiting entirely with an estimated $61.7K sold.
- 5 institutional investors held Molecular Partners (MOLN) as of Q2 2026, up from 4 in Q1 2026.
- Funds reported $13.8M of Molecular Partners stock for Q2 2026, down 3% quarter-over-quarter.
- 2 funds opened new Molecular Partners positions in Q2 2026 and 1 closed out, a net change of +1 holder.
- The largest Molecular Partners buyer in Q2 2026 was Citadel Advisors, an estimated $69.7K added.
- The largest Molecular Partners seller in Q2 2026 was SmartHarvest Portfolios, an estimated $61.7K sold.
Based on aggregated 13F filings for Q2 2026.